Informa Results Presentation Deck
gap Accelerating Shareholder Returns
Return c50% of post tax proceeds from GAP II Portfolio Focus programme
Pharma Intelligence divestment completed for £1.9bn - post-tax proceeds of c.£1.5bn
Share Buyback Programme launched on 14 February 2022
●
●
●
£725m
Total capital
returns now
committed
Tranche 1 completed:
17m shares repurchased and cancelled at average price of 587p
£100m of total value returned to Shareholders by 14 March 2022
Tranche 2 near completion:
Further £200m committed to buybacks for a total of £300m
c.£290m of total value returned to Shareholders by 15 June 2022
Tranche 3 to follow:
●
●
Further £425m committed to buybacks for a total of £725m
Expected to be completed by year-end 2022
Ordinary dividend to resume from interim dividend 2022
2022 Annual General Meeting
Commitment to Share Buybacks raised to £725m
****
informa
c.£290m
Capital returned to date
575.7p
Average share price
50.3m
Shares cancelled
15View entire presentation